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ABSTRACT   1 
The QseEF histidine kinase/response regulator system modulates expression of 2 
enterohemorrhagic E. coli (EHEC) and Salmonella enterica serovar Typhimurium (Stm) 3 
virulence genes in response to the host neurotransmitters epinephrine and norepinephrine. QseG, 4 
which encodes an outer membrane lipoprotein, is co-transcribed with qseEF in these enteric 5 
pathogens, but there is little knowledge of its role in virulence. Here, we found that in EHEC 6 
QseG interacts with the type three secretion system (T3SS) gate protein SepL, and modulates the 7 
kinetics of attaching and effacing (AE) lesion formation on tissue-cultured cells. Moreover, an 8 
EHEC ∆qseG mutant had reduced intestinal colonization in the infant rabbit model. Additionally, 9 
in Citrobacter rodentium, an AE lesion-forming pathogen like EHEC, QseG is required for full 10 
virulence in a mouse model. In Stm, we found that QseG regulates the phase switch between the 11 
two flagellin types, FliC and FljB.  In an Stm ΔqseG mutant, the phase variable promoter for fljB 12 
is preferentially switched into the ‘on’ position, leading to an overproduction of this ‘phase two’ 13 
flagellin.  In infection of tissue-cultured cells, the ΔqseG Stm mutant provokes increased 14 
inflammatory cytokine production vs wild-type; in vivo, in a murine infection model, the ΔqseG 15 
strain caused a more severe inflammatory response, and was attenuated vs the wild-type strain.  16 
Collectively, our findings demonstrate that QseG is important for full virulence in several enteric 17 
pathogens and controls flagellar phase variation in Stm, and highlight both the complexity and 18 
conservation of the regulatory networks that control the virulence of enteric pathogens. 19 
 20 
 21 
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INTRODUCTION 1 
The gastrointestinal tract is a diverse ecosystem with many physiologically distinct 2 
niches.  To mount a productive infection, bacterial pathogens that infect the gut must be able to 3 
sense these niches and deploy their virulence regime in the appropriate environment. Aberrant 4 
deployment of virulence factors may lead to wasted energy or detection by the host immune 5 
system. To accomplish this task many bacterial pathogens have evolved highly complex 6 
regulatory networks to control expression of their virulence factors. Understanding these 7 
complex regulatory systems will lead to a greater understanding of disease progression (1).  8 
Two component systems are a common strategy used by bacterial pathogens to regulate 9 
virulence genes in response to environmental cues (2). Both enterohemorrhagic E. coli (EHEC) 10 
and Salmonella enterica serovar Typhimurium (Stm) use the QseEF two-component system to 11 
sense host hormones and regulate expression of virulence genes.  The sensor kinase QseE senses 12 
epinephrine, norepinephrine, phosphate and sulfate and phosphorylates its cognate regulator, 13 
QseF.  In EHEC, QseF induces transcription of espFu (3, 4), a type III secretion system (T3SS) 14 
effector that interacts with host proteins to activate actin polymerization and initiate formation of 15 
attaching and effacing (AE) lesions (5-7).  In Stm, QseEF signaling enhances expression of the 16 
SPI-1 pathogenicity island (8), which encodes a T3SS and is necessary for host cell invasion (9). 17 
In a mouse model of systemic infection a Stm strain lacking qseE is significantly attenuated 18 
compared to WT (8). Although conserved across these two species, the QseEF system has 19 
undergone species specific specialization to regulate virulence factors unique to each pathogen.  20 
 The qseG gene is located between qseE and qseF on the chromosome, and co-transcribed 21 
with this two-component system. Homologs of qseG are present in many of the 22 
Enterobacteriaceae, however, all previous work investigating QseG function has been carried 23 
 4 
out in EHEC. QseG is an outer membrane lipoprotein that is transported through the general 1 
secretory pathway (Sec) or the twin arginine translocation (Tat) system (known to transport 2 
folded proteins (10, 11)) (4). QseG is predicted to contain alpha-helices but lacks significant 3 
homology to other proteins in the database. In an EHEC qseG deletion mutant expression of 4 
qseE is increased, suggesting that QseG modulates expression of the two-component system.  5 
QseG is not required for secretion of T3SS components or effectors, but impacts the 6 
translocation of the translocated intimin receptor (Tir) (4). Tir is the first effector translocated 7 
into the host cell via the T3SS (12). It interacts with intimin on the bacterial membrane to 8 
promote tight adherence, and interacts with host proteins to promote actin polymerization and 9 
A/E lesion formation (13). Because QseG impacts translocation of Tir, and potentially other 10 
effectors, a strain lacking qseG does not form A/E lesions efficiently (4). These data suggest that 11 
qseG is important for EHEC virulence; moreover, since qseG along with qseEF is conserved 12 
among many of the pathogenic enterobacteriacae, it may play an important role in regulating 13 
virulence across many pathogens. 14 
Here we show that qseG is required for full virulence in animal models of EHEC, 15 
Citrobacter rodentium, a related AE pathogen, and Stm infection. We show that although QseG 16 
is important for full virulence in animal models of both EHEC and Stm infection, its mechanism 17 
of action has diverged. In Stm QseG plays a role in modulating flagellar phase variation—a 18 
system that is missing from EHEC. This phase variation regulation leads to decreased 19 
inflammation at systemic sites during Stm infection. The qseEFG operon is found in the 20 
genomes of many Enterobacteriaceae and it is likely that QseG plays an important role in other 21 
species as well. Our work highlights both the complexity of the regulatory networks that 22 
 5 
bacterial pathogens employ, as well as that proteins common to different pathogens can adapt to 1 
serve species specific roles. 2 
 3 
RESULTS 4 
QseG faces the periplasm and interacts with SepL. QseG contains a predicted lipid 5 
attachment site and previous work using cell fractionation demonstrated that QseG is located in 6 
the EHEC outer membrane (4).  To determine whether QseG is exposed to the outside of the cell, 7 
or instead faces the periplasm, a proteinase K protection assay was performed (Fig. 1A).  Cells 8 
were treated with the membrane impermeable protease proteinase K, and the effect on QseG and 9 
OmpA, as a control, was assessed by western blot. Levels of OmpA, which is exposed to the 10 
outside of the cell, were diminished by proteinase K treatment. In contrast, levels of QseG were 11 
unchanged by proteinase K treatment, suggesting it is not exposed to the outside of the cell and 12 
therefore likely faces the periplasm.  13 
QseG is not involved in the expression of the LEE or espFu genes, or in the assembly of 14 
the TTSS, but impacts the translocation of  Tir into host cells (4). We hypothesized that QseG, 15 
because of its cellular location, may physically interact with components of the T3SS apparatus 16 
and thereby have a role in modulating the T3SS. Using a yeast two-hybrid assay, QseG was 17 
tested for its ability to interact with various components of the T3SS thought to be present in the 18 
periplasm. Of the proteins screened, only SepL was identified as a potential binding partner for 19 
QseG (Fig 1B). SepL, along with SepD, are required for secretion of EspA, EspB and EspD (14, 20 
15), the structural components of the T3SS known as the translocon.  Furthermore they are 21 
responsible for regulating the switch from secretion of the translocon to secretion of effector 22 
proteins (14, 16). SepL directly binds to Tir to prevent its early secretion (17), but the signal that 23 
 6 
initiates the switch to begin secretion of effectors is not fully defined. Co-immunoprecipitation 1 
was employed to confirm the interaction of QseG with SepL. An HA-tagged allele of sepL was 2 
expressed in a ∆sepL or ∆sepL∆qseG strain of EHEC and a pull-down performed using an anti-3 
HA antibody. When both SepL-HA and QseG were present, QseG was detected via western blot 4 
in the precipitated sample using an anti-QseG antibody (Fig. 1C), confirming the SepL-QseG 5 
interaction. The direct interaction of QseG with SepL in EHEC suggests that QseG may play a 6 
role in regulation of the T3SS, and may play a role in the switch from translocon to effector 7 
secretion. Because Tir translocation is a key event in AE lesion formation we investigated AE 8 
lesion formation by the ∆qseG using live cell imaging. The ∆qseG mutant exhibited delayed and 9 
was almost abrogated in its ability to form AE lesion on epithelial cells compared to WT. The 10 
∆qseG mutant does not have any growth defects compared to WT (18), and previous AE lesion 11 
assays are congruent with the live cell image, showing that ∆qseG is defective for AE lesion 12 
formation and that this defect can be complemented (4). Taken together, these data suggest that 13 
differences in Tir translocation impact the kinetics of pedestal formation (Fig. 2, Movies S1 and 14 
S2).  15 
QseG is required for robust colonization and full virulence in in vivo models of 16 
EHEC infection. QseG impacts Tir translocation and is required for efficient pedestal formation 17 
(4).  To test if this defect in T3SS activity translates to attenuated colonization and virulence in 18 
vivo, we used two different small animal models of EHEC infection.  We infected infant rabbits 19 
with wild-type (WT) or a ∆qseG mutant of the 86-24 EHEC strain and measured bacterial load in 20 
the colon 5 days post infection.  Significantly fewer CFUs were recovered from rabbits infected 21 
with ∆qseG compared to WT (Fig. 3A), demonstrating that QseG contributes to efficient 22 
colonization in this model.  We also tested the role of QseG in vivo using Citrobacter rodentium, 23 
 7 
a natural pathogen of mice that is closely related to EHEC.  The C. rodentium genome also 1 
harbors the LEE (19) and many of the regulatory pathways that control its expression are 2 
conserved between C. rodentium and EHEC.  Importantly, where EHEC’s virulence in mice can 3 
be solely attributed to Shiga-toxin (20), C. rodentium infection in mice exhibits many of the 4 
hallmarks of EHEC disease in humans including AE lesion formation, colonic hyperplasia and 5 
diarrhea (21, 22), making it a useful model for studying LEE regulation in vivo.  Mice infected 6 
with a ∆qseG mutant survived significantly longer than those infected with WT C. rodentium 7 
(Fig. 3B). ∆qseG infected mice also displayed attenuated disease symptoms compared to WT.  8 
The ∆qseG infected mice had decreased colon weights (consistent with decreased colonic 9 
hyperplasia (16, 23, 24)) (Fig. 3C), and their stool was formed in normal pellets where WT 10 
infected mice displayed unformed, liquid diarrheal feces. (Fig. 3D). The increased survival and 11 
attenuation of disease symptoms where qseG is absent indicates that this gene is required for full 12 
virulence in vivo. 13 
Absence of qseG leads to overproduction of the Stm type II flagellin. The QseEF two-14 
component system regulates type III secretion in both EHEC and Stm and is required for full 15 
virulence in both pathogens (4, 8, 25, 26).  We hypothesized that qseG modulates virulence in 16 
Salmonella as well, and studying its role in this pathogen could help uncover its mechanism of 17 
action. A sequence alignment of the qseEFG operon of EHEC and Stm revealed that the 18 
sequence similarity of qseG was lower at both the nucleotide and protein level (59/88% 19 
respectively) than the surrounding qseE (71/94%) and qseF (81/98%) genes (Fig. 4A). This 20 
suggests that QseG has undergone greater adaptation than the QseEF two-component system 21 
with which it is co-transcribed. We know that QseEF regulon differs between EHEC and Stm, 22 
 8 
controlling virulence factors specific to each species, therefore we hypothesized that the role of 1 
QseG may differ between these two pathogens as well.  2 
We created a qseG deletion mutant in the Stm SL1344 strain and confirmed that, as with 3 
the corresponding EHEC mutant (18), it displayed identical growth kinetics to WT Stm in vitro 4 
(data not shown). We then analyzed the secreted proteome of WT vs ∆qseG Stm by SDS-PAGE 5 
and Coomaisie staining.  The supernatant of an ∆invA∆spiB mutant, which is deficient in both 6 
the Salmonella T3SSs encoded in pathogenicity islands SPI-1 and SPI-2, was run as a control to 7 
identify proteins secreted through T3SS.  Compared to WT the ∆qseG mutant did not appear to 8 
have any change in the amounts of T3SS secreted proteins.  However, a large band appeared in 9 
the ∆qseG supernatant that was not observed in the WT supernatant (Fig. 4B).  The unknown 10 
band was extracted and identified by mass spectrometry as FljB (Table 1), the Stm phase II 11 
flagellin.  Unlike E. coli, many strains of Salmonella possess two antigenically distinct alleles of 12 
the flagellin protein: fliC and fljB (27).  fljB, the “phase II” flagellin, is under the control of an 13 
invertible promoter that in the on position leads to transcription of fljB and the repressor of fliC, 14 
fljA, leading to reciprocal control of the two flagellin types (28-33).  A relative quantification of 15 
the total secreted proteome was performed by mass spectrometry (Table 1), confirming that 16 
∆qseG mutant supernatants contained nearly 50-fold higher FljB protein levels compared to WT 17 
supernatants (Fig. 4B).  A corresponding decrease in FliC levels was observed as expected, but 18 
no other significant changes in flagella-associated proteins were observed. The secreted 19 
proteome analysis also confirmed that no significant, consistent change in SPI-1 secreted 20 
proteins was observed (Table 1). 21 
QseG decreases fljB transcription by modulating its invertible promoter to favor the 22 
off position. To test whether increased FljB secretion in the ∆qseG mutant was modulated at the 23 
 9 
transcriptional level, we measured fljB RNA levels using qPCR.  fljB transcript was increased 1 
over 100-fold in ∆qseG Stm compared to WT and a corresponding, but more modest, decrease in 2 
fliC transcript was also observed.  Importantly, complementation of qseG in trans restored fljB 3 
and fliC transcript to WT levels (Fig. 4C).  As fljB is controlled by an invertible promoter, we 4 
tested whether the observed increase in fljB transcription was due to an increase in the proportion 5 
of fljB promoters that were in the “on” position.  A qPCR based assay was designed where one 6 
primer is located within the invertible region and one outside, such that the molar ratio of the 7 
orientations can be calculated.  In the WT strain the “off” orientation was favored by a ratio of 8 
over 100:1. In the absence of qseG the ratio was altered to closer to 1:1, with the “on” position 9 
being slightly favored (Fig. 4D). qseG complementation restored the on/off ratio to WT levels. 10 
These observations reveal that QseG modulates the orientation of the fljB promoter to repress 11 
fljB expression. 12 
Absence of qseG does not affect Stm motility, cell invasion or intracellular 13 
replication. Because QseG was involved in regulation of flagellin transcription, we 14 
hypothesized that the mutant may have an altered motility phenotype. Motility was assessed 15 
using a soft agar swimming assay but no significant alteration in motility was observed (Fig. 16 
5A). This was not entirely unexpected, as we have not demonstrated that QseG represses overall 17 
flagella expression, but rather modulates which flagellin allele is favored. In a HeLa cell-based 18 
invasion assay the ∆qseG mutant did not display any defects in cell invasion in vitro (Fig. 5B). 19 
Similarly, no defects in intracellular replication were observed in the ∆qseG mutant either in 20 
human (Fig. 5C) or mouse (Fig. 5C) macrophages. Defects in cell invasion and intracellular 21 
replication are typically phenotypes associated with defects in the T3SS1 or T3SS2 respectively, 22 
 10 
and since we did not observe any differences in the amount of secreted proteins associated with 1 
either of these two systems, a lack of phenotype is not unexpected. 2 
QseG is required for full Stm virulence in mice. To assess the importance of QseG in 3 
vivo we utilized a murine model of systemic disease where mice are infected intraperitoneally 4 
with Stm. At days two and three post infection, groups of five mice were sacrificed and spleens 5 
and livers were collected to enumerate bacterial loads.  Data shown is combined from two 6 
independent experiments. Mice infected with the ∆qseG mutant survived significantly longer 7 
than those infected with WT Stm (Fig. 6A), demonstrating that qseG is required for full 8 
virulence in this model of Stm infection.  The ∆qseG mutant infected mice also appeared to lose 9 
slightly less weight compared to WT infected mice (Fig. 6B), although this was not statistically 10 
significant.  Interestingly, no significant differences in bacterial loads were observed at either 11 
day two or three in the liver or spleen of infected animals (Fig. 6C).  Since QseG contributes to 12 
Stm virulence, but is not required for efficient colonization or proliferation in this model, it is 13 
possible that it augments virulence by modulating the host response to infection. 14 
QseG limits inflammation during Stm infection. QseG modulates expression of the 15 
flagellin proteins, which are “pathogen associated molecular patterns” and potent activators of 16 
the immune system.  Flagellins are recognized by Toll-like receptor-5 (34) leading to cytokine 17 
and nitric oxide production (35) and by the NOD-like receptors NLRC4 and NAIP5, leading to 18 
activation of the inflammasome (36). To test whether QseG has a role in modulating the 19 
inflammatory response during Stm infection we exposed T84 colonic epithelial cells to 20 
supernatants from different strains of Stm and monitored the induction of IL-8 transcription by 21 
qPCR (Fig. 7A). Cells exposed to supernatants from WT Stm showed approximately 50-fold 22 
induction of IL-8 transcript compared to uninfected cells. Supernatants from ∆fliC∆fljB Stm 23 
 11 
caused no IL-8 induction, suggesting that any IL-8 induction observed in this assay can be 1 
attributed to the flagellin response.  Supernatants from ∆qseG Stm significantly increased IL-8 2 
transcription compared to WT supernatants, resulting in nearly 100-fold induction over 3 
uninfected cells.  Supernatants from a ∆qseG∆fljB double mutant resulted in a slightly dampened 4 
IL-8 response compared to ∆qseG Stm however, this was not statistically significant and IL-8 5 
levels were not reduced to those measured with WT Stm supernatants. We hypothesize that 6 
because there is significant crosstalk between fliB and fliC expression and that deletion of fljB 7 
could lead to increased fliC expression compensating for the of FljB.  Additionally, it is possible 8 
that the ∆qseG Stm increases inflammatory cytokine production through another mechanism 9 
other than modulating fljB expression.   10 
To confirm the role of QseG in modulating the fljB promoter in vivo, DNA from infected 11 
livers and spleens was collected and the orientation of the fljB promoter was assessed via the 12 
qPCR-based assay described above. A higher proportion of the fljB promoter was in the on 13 
position in livers and spleens from ∆qseG Stm infected mice compared to WT infected mice 14 
(Fig. 7B), confirming that the modulation of the fljB promoter by QseG is occurring in vivo 15 
during infection. To test the effect of QseG on the inflammatory response we collected RNA 16 
from infected livers and spleens and assayed for host expression of the inducible nitric oxide 17 
synthase, NOS2. A significant increase in NOS2 expression was observed in livers infected with 18 
∆qseG Stm compared to WT (Fig. 7C), suggesting that QseG does indeed dampen the 19 
inflammatory response to Stm, perhaps through its modulation of fljB expression.   20 
 21 
DISCUSSION 22 
 12 
 To establish a productive infection, intestinal pathogens must tightly regulate their 1 
virulence systems, deploying them at the appropriate sites and times during infection. Likewise, 2 
pathogens need to dampen expression of genes that provoke inflammatory responses when they 3 
are not needed to escape detection by the host immune system.  4 
The signaling networks that control pathogen gene expression during infection are 5 
extremely complex, and often integrate many different environmental signals. Here, we 6 
investigated the function of QseG, a protein conserved in many pathogenic Enterobacteriaceae, 7 
but which lacks significant homologues in the database. qseG is co-transcribed with qseEF, a 8 
two-component system known to control critical virulence genes in both EHEC and Stm. 9 
Notably, we found that QseG is required for full virulence in EHEC, C. rodentium and Stm. 10 
However, we found that the sequence similarity of qseG between EHEC and Stm was lower than 11 
for the surrounding genes, suggesting that its function may have diverged in these two species.  12 
Our data indeed supports that although qseG is required for full virulence by both EHEC and 13 
Stm, its mechanism of action differs between these two pathogens. 14 
In EHEC, we found that QseG interacts with a component of the T3SS, SepL, but the 15 
nature of this interaction, and its significance, remains undefined. Interestingly, SepL and its Stm 16 
homolog SsaL share only 35% similarity (37) and sepL cannot fully complement an ssaL mutant 17 
(38). Therefore we do not expect that SepL and SsaL will play equivalent roles in regards to their 18 
interactions with QseG.  19 
Previous studies have shown that QseG impacts the translocation of Tir but not its 20 
secretion.  This, along with its interaction with SepL, suggests that QseG is involved in 21 
regulation of T3SS function. QseG’s location in the inner leaflet of the outer membrane, and its 22 
lack of any predicted signal transduction motifs, suggest that its regulatory role may be carried 23 
 13 
out through protein-protein interactions, with SepL and potentially other components of the 1 
T3SS apparatus.  The QseEF two-component system controls transcription of the T3SS effector, 2 
espFu; thus, the qseEGF operon may control the activity of EHEC’s T3SS at several levels. 3 
In Stm, we found that QseG modulates the invertible promoter controlling expression of 4 
the flagellin gene fljB, leading to repression of this flagellin allele. However, QseG does not alter 5 
motility in Stm. This flagellin switch does not exist in EHEC, and in EHEC QseG also does not 6 
play any role in motility or flagella expression (data not shown). QseG also has a role in 7 
controlling the inflammatory response to Stm that we hypothesize is mediated through its role in 8 
controlling fljB expression.  Previous studies have shown that strains that are locked into 9 
expressing fljB are attenuated in mouse models of infection compared to both WT and a “locked 10 
off” strain that expresses fliC, suggesting a disadvantage to expressing fljB in a mammalian host 11 
(39). Interestingly, purified recombinant FliC and FljB activate NF-κB to comparable levels in 12 
vitro (40), suggesting that FljB is not inherently more inflammatory than FliC.   13 
We propose that while flagella is important during the intestinal phase of infection, 14 
expression of flagellin, and particularly FljB, is detrimental for Stm at systemic sites (Fig. 8).  15 
During the systemic phase of infection, QseG is important for modulating the fljB promoter to 16 
favor the off position—leading to diminished FljB secretion.  This leads to decreased NOS2 and 17 
cytokine induction and decreased overall inflammation at systemic sites.  18 
Several studies have demonstrated extensive cross-talk between regulation of SPI-1 and 19 
flagella in Stm (41-49). We have previously shown that QseEF activates expression of SPI-1 and 20 
now we have demonstrated that QseG regulates expression of flagellin, suggesting that the 21 
qseEGF operon is another player in the crosstalk between these two critical systems. However, 22 
 14 
further studies are needed to define whether there are interactions between QseEF and QseG and 1 
their respective regulons. 2 
While we have demonstrated that QseG modulates the fljB promoter in Stm, we have also 3 
shown previously that it is localized to outer membrane in EHEC (4). The localization of QseG 4 
poses an interesting question on how it excerts its effect on the orientation of the fljB DNA 5 
promoter. One possibility is that it interacts with other proteins that relay the message from the 6 
periplasm to the cytoplasm and exert effects on the promoter. We have found that QseG has at 7 
least one direct binding partner in EHEC, SepL, but we have yet to identify any proteins that 8 
interact with QseG in Stm. The focus of future studies will be to determine proteins that QseG 9 
may interact with to carry out its function modulating the fljB promoter.  Another potential, 10 
albeit less likely, mechanism is that QseG itself interacts with DNA or cytoplasmic DNA binding 11 
proteins before it is lipidated and secreted to the outer membrane. As there are no putative DNA 12 
binding domains we do not expect QseG to bind DNA itself but future studies will seek to 13 
identify protein binding partners. 14 
QseG modulates flagellar phase variation in Stm but paradoxically, QseG is present 15 
EHEC and other Enterobacteriacaea whose genomes encode only a single flagellin, fliC. 16 
Clearly, there has been some functional divergence of QseG across species, which is reflected by 17 
the 62% sequence identify between the Stm and EHEC proteins. This specialization is also seen 18 
in the QseEF two-component system that is co-transcribed with qseG. In both EHEC and Stm, 19 
QseEF controls expression of critical virulence factors, however the particular genes it controls 20 
are species specific. However, as the presence of the qseEGF operon has been conserved across 21 
many pathogenic Enterobacteriacaea, there may still be a common, undefined function. 22 
 15 
 The work presented here highlights the idea that conserved systems across different 1 
species can evolve and be tuned to perform species-specific functions. Thus, while QseG is 2 
required for full virulence in both EHEC and Stm, this outer membrane protein performs distinct 3 
functions in these two species. Furthermore, this work highlights the complexity of the 4 
regulatory networks that bacterial pathogens use to modulate expression of their virulence genes. 5 
Many systems incorporate several layers of regulation as well as cross-talk between different 6 
virulence-associated systems, such as a T3SS and flagellins, which we still do not fully 7 
understand. Uncovering the mechanistic basis for virulence gene regulation will allow us to more 8 
fully understand how pathogens cause disease and may help in developing more effective 9 
therapeutics.   10 
 11 
MATERIALS AND METHODS 12 
Bacterial strains and plasmids. All bacterial strains and plasmids used in this study are listed in 13 
Table 2. EHEC and Stm deletion mutants were created using λ red mutagenesis (50). Stm QseG 14 
complementation plasmid was created via restriction digest/ligation into the pBAD/Myc-His A 15 
backbone. The complementation plasmid was induced with 0.2% arabinose. Primers used in this 16 
study are listed in Table 3. 17 
Proteinase K protection assay. Proteinase K protection assays were performed as 18 
previously described (51). 19 
Yeast two-hybrid screen. A yeast two hybrid was used as previously described (52) to 20 
test for possible protein-protein interaction between QseG and QseG, EscC, EspA, SepD, SepL 21 
and Tir.  Briefly, the yeast report strain L40 was transformed (53) with all combinations of the 22 
proteins in both the bait (pLEX-ADE) and the library (pVP16) vector.  Dual transformants were 23 
 16 
selected on yeast minimal media lacking leucine, and tryptophan and then assayed for protein-1 
protein interactions using the integrated LacZ and HIS3 reporters.  Association of the two protein 2 
fusions was determined by growth on yeast minimal media lacking histadine.   3 
Co-immunoprecipitation. Co-immunoprecipitation of SepL and QseG was performed 4 
using SepL-HA (14) and anti-HA antiserum, and an anti-QseG antiserum (4) from EHEC 5 
expressing SepL-HA on a plasmid, as previously described (54). 6 
Live cell imaging.  Live cell imaging was performed as previously described (55). The 7 
Lifeact::GFP expressing cell line was created using the Flip-In System (Invitrogen).  HeLa cells 8 
were transfected with pLacZ::Zeocin using Fugene 6 (Promega) to create FRT sites in the 9 
genome.  Cells were then selected with 100µg/ml zeocin.  Resistant foci were grown and assayed 10 
by Southern blot against lacZ for single insertions, and then β-galactosidase assays were 11 
performed to measure expression of the inserted locus.  High expressing single insertions were 12 
then transfected with the flippase helper plasmid pOD44 and Lifeact::GFP cloned into pFRT 13 
plasmid.  These transfected cells were then selected in 100µg/ml hygromycin, and resistant foci 14 
were visualized under fluorescent microscopy to measure levels of Lifeact::GFP expression.  15 
These cells were then maintained in 50µg/ml hygromycin.  When they are split before infection 16 
hygromycin is not added.  EHEC were transformed with the mCherry expressing plasmid 17 
pDP151 and grown ON statically in LB.  The Lifeact::GFP cell’s media was replaced with low 18 
glucose DMEM supplemented with 10% FBS and infected with a 1:100 dilution of the ON.  The 19 
infection was allowed to continue for 2hrs at 37oC and 5% CO2 and then the cells are washed 3 20 
times with DMEM and then visualized by live cell imaging with a Zeiss scope.  Images are taken 21 
every 2 minutes for 2 hours. 22 
 17 
Infant rabbit model of EHEC infection. To prepare the inoculum, bacteria were grown 1 
overnight in LB broth at 37°C with appropriate antibiotics, harvested by centrifugation and 2 
resuspended in sterile PBS (pH 7.2) and adjusted to a cell density of ~ 109 CFU ml-1.  Infant 3 
rabbit experiments were carried out as described previously (56). Briefly, 3-day-old New 4 
Zealand White rabbits were intragastrically inoculated with ~5 x 108 CFU of WT EHEC or the 5 
qseG mutant using a size 5 French catheter.  Rabbits were monitored twice daily for signs of 6 
illness or diarrhea.  Diarrhea was described as i) none – normal pellets are dark green, hard and 7 
formed, ii) mild – diarrhea consisting of a mix of soft yellow-green unformed and formed pellets 8 
resulting in light staining of the hind legs, or iii) severe – diarrhea consisting of unformed or 9 
liquid feces, resulting in significant staining of the hind legs.  Rabbits were euthanized at 2 and 5 10 
days post-infection.  At necropsy, the intestinal tract from the duodenum to the anus was 11 
removed and samples obtained for microbiologic analyses.  To limit any litter-specific effects, at 12 
least two different litters were used to test each bacterial strain. 13 
Citrobacter rodentium murine infections. For mouse survival experiment, ten 3.5 week 14 
old female C3H/HeJ or 129x1/SvJ mice per group were infected by oral gavage with multiple 15 
infectious doses of wild type, or ∆qseG C. rodentium strains by oral gavage with 100 µl of PBS. 16 
Mouse survival in each group (10 animals per group) was accessed over the course of 14 to 26 17 
days. Kaplan meyer test was used to determine statistical significance. For colon weight 18 
measurement, five 3.5 week old female C3H/HeJ mice per group (5 animals per group) were 19 
infected with 1x109 cells of wild type wild type or ∆qseG C. rodentium. The infected mice were 20 
sacrificed on day 6 post infection, and their colons were taken, washed and weighed 21 
Salmonella typhimurium. 9-12 week old female Balb/c mice were infected 22 
intraperitoneally with 1x104 CFU SL1344 in PBS or sterile PBS as a control. Two independent 23 
 18 
experiments were performed, each with 15 mice per group (10 for survival, 5 for organ 1 
collection).  Survival was monitored and weight measured daily. On day 2 (1st experiment) or 2 
day 3 (2nd experiment) 5 randomly selected mice were sacrificed and livers and spleens 3 
homogenized and plated on LB agar + streptomycin to enumerate CFUs. Weight and survival 4 
data from the two independent experiments were combined. A student’s t-test was used to 5 
compare weight loss between the different groups on each day and the survival curves were 6 
analyzed using the Mantel-Cox test.  7 
To measure fljB promoter orientation and NOS2 expression in infected tissues, portions of liver 8 
and spleen were collected into Trizol and total DNA and RNA was extracted according to 9 
manufacturer’s instructions. The fljB promoter orientation was measured in the extracted DNA 10 
using the qPCR standard curve method outlined below. NOS2 levels were assayed from 11 
extracted RNA via qPCR as described below. NOS2 readings were normalized to GAPDH levels 12 
and reported as a fold-change over levels from uninfected (PBS treated) mice. Average and 13 
standard deviations across the five mice are reported and statistical significance was calculated 14 
using a student’s unpaired t-test. 15 
Secreted proteome analysis. SL1344 strains of Stm were grown to late log phase in LB.  16 
Cells were pelleted and supernatants filtered through 0.2um filter and concentrated using 17 
Amicon 10kDA MWCO concentrators (Millipore). Samples from concentrated supernatants 18 
were run under denaturing conditions on 12% SDS-PAGE gels and stained using Bio-safe 19 
Coomaisie (Biorad).  The unknown band that appeared in the ∆qseG sample was extracted from 20 
the gel and submitted for identification by LC-MS/MS by the UT-Southwestern proteomics core 21 
facility.  For total protein identification and quantification concentrated supernatants from WT 22 
and ∆qseG Stm were loaded onto SDS-PAGE gel and run just until samples entered the 23 
 19 
resolving gel. The sample was extracted from the resolving gel and submitted for LC-MS/MS 1 
analysis to the UT-Southwestern proteomics core.     2 
Quantitative real-time PCR. For in vitro transcription analysis Stm was grown to OD600 3 
1.0 in LB.  RNA was extracted and DNAse treated as described in (57). Quantification of RNA 4 
transcript levels was performed as described previously(58).  Primer pairs were validated for 5 
amplification efficiency and specificity using a standard curve of diluted RNA. Sample RNA 6 
was mixed with SYBR master mix, validated primers, RNAse inhibitor and reverse transcriptase. 7 
A one-step reaction was run using ABI 7500 system and data was analyzed using the ABI 8 
sequence detection 1.2 software.  Values were normalized to endogenous rpoA and analyzed by 9 
the comparative critical threshold method. Values are presented as fold-change over WT levels 10 
and the average and standard deviation from three independent replicates is represented.  11 
fljB promoter orientation assay. DNA was extracted from strains grown as described 12 
above using Sigma bacterial genomic DNA extraction kit.  A “universal” primer was designed 13 
within the invertible element and “on” and “off” primers were designed outside the invertible 14 
element such that a product would only be amplified when the promoter was in the designated 15 
position. Amplicons for each orientation were synthesized via conventional PCR, purified and 16 
diluted to make a standard curve of known quantities. Standard curves were used to determine 17 
the quantity of each orientation in unknown samples, which were converted to mol and the molar 18 
ratio of on to off was calculated. 19 
Swimming motility assay. Motility assays were performed as described previously (59). 20 
Briefly, strains were grown in LB broth + 0.2% arabinose to induce complementation plasmid 21 
shaking at 37°C until they reached OD 1.0. Cells were stabbed into LB plates containing 0.3% 22 
 20 
agar and incubated at 37°C. Motility halos were measured at indicated time points. Average and 1 
standard deviation between three replicates is displayed.  2 
Cell invasion assay. HeLa epithelial cells were routinely cultured in DMEM (Gibco) 3 
supplemented with 10% fetal bovine serum in 5% CO2. Invasion assay was performed as 4 
described previously (60). Briefly, HeLa cells were seeded at 1x105 per well in 24-well plates 24 5 
hours prior to infection. Overnight Stm cultures were diluted into fresh LB and grown to OD 1.0, 6 
washed in sterile PBS and resuspended to 1X in pre-warmed DMEM media. Cells were washed 7 
x3 with pre-warmed PBS and infected at an MOI of 10. Plate was spun at 1000xg for 5 minutes 8 
and incubated at 37°C in 5% CO2 for 90 minutes. Media was removed, cells washed and DMEM 9 
+ gentamycin (30ug/mL) was added to kill extracellular bacteria. Cells were incubated for an 10 
additional 60 minutes before removing media and washing with PBS x3. Cells were lysed by 11 
incubating in 1mL 1% Triton X-100 in PBS at room temperature for 5 minutes. Cell lysates and 12 
the bacterial inoculum were diluted in PBS and plated on LB agar with streptomycin to 13 
enumerate CFUs. 14 
Intracellular replication assay. J774 mouse macrophages or THP-1 human 15 
macrophages were seeded in 24-well plates and grown to confluency over 2 days. To prepare 16 
inoculum bacteria were diluted from an overnight culture 1:10 into fresh LB medium and grown 17 
to OD 1.0 at 37°C shaking. Bacteria were washed with PBS x2 then resuspended in cell culture 18 
media. Cells were infected at an MOI of 5 and plates were spun at 1000xg for 5min to maximize 19 
bacteria-cell contact. Infected cells were incubated for 30 minutes at 37°C, 5%CO2. Media was 20 
removed and cells were washed x3 with warm PBS. Cell culture media + 30µg/mL gentamycin 21 
was added to kill extracellular bacteria. After 3 hours samples were collected by removing 22 
media, washing wells x3 with PBS then adding 1mL 0.1% Triton X-100 to each well. After 23 
 21 
incubating for 5 minutes cell lysates were collected. For 24 hour samples, media was removed at 1 
3 hours and replaced with media containing 10µg/mL gentamycin. At 24 hours post infection 2 
wells were washed and cells lysed as described above. Serial dilutions of lysates were plated on 3 
LB agar + streptomycin to enumerate CFUs. Averages and standard deviations for three 4 
independent experiments are shown. 5 
IL-8 expression by T84 cells. The T84 (ATCC CCL-248) human colorectal carcinoma 6 
cell line was routinely cultured in DMEM-F12 media (Gibco) supplemented with 10% heat 7 
inactivated fetal bovine serum (Gibco). Cells were seeded in 6-well plates at a density of 1x105 8 
cells per well, grown for 48 hours. 24 hours prior to infection cell culture media was removed 9 
and replaced with serum-free media. SL1344 strains were grown to OD 1.0 shaking in LB media. 10 
Cells were pelleted and supernatants were filtered and concentrated ~60X with 10kDa MWCO 11 
Amicon concentrators (Millipore). Concentrated supernatants or purified flagellin (InvivoGen) 12 
were added to T84 cells in triplicate.  One hour post-addition, media was removed and cells were 13 
washed x3 with pre-warmed sterile PBS. 1mL Trizol was added to each well and cells were 14 
collected into Eppendorf tubes. RNA was extracted via manufacturer’s instructions. DNA was 15 
degraded using Turbo DNase (Ambion) and cDNA was synthesized using Superscript II reverse 16 
transcriptase (Invitrogen) according to manufacturer’s instructions. 50ng of cDNA was used per 17 
reaction with SYBR master mix and validated primers using ABI 7500 system. To ensure no 18 
gDNA remained, control reactions were run with RNA as the template. Data was analyzed using 19 
the ABI sequence detection 1.2 software.  Values were normalized to endogenous GAPDH and 20 
analyzed by the comparative critical threshold method. Values are presented as fold-change over 21 
untreated cells. Average and standard deviation were calculated across triplicate wells and 22 
statistically significant differences were determined via student’s t-test. One representative 23 
 22 
experiment is shown but three independent experiments were performed to ensure 1 
reproducibility.  2 
 3 
SUPPLEMENTAL MATERIAL 4 
SUPPLEMENTAL FILE 1, live cell movie of WT EHEC on HeLa cells 5 
SUPPLEMENTAL FILE 2, live cell movie of ∆qseG EHEC on HeLa cells 6 
 7 
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Table 1: Mass spec analysis of secreted proteins in WT vs qseG- SL1344 1 
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Table 2. Strains and plasmids 1 
Strain Genotype Reference 
86-24 Stx+ EHEC strain serotype O157:H7 (61) 
NRO2 86-24 ∆qseG  (4) 
CG04 ∆sepL This study 
CG05 ∆sepL∆qseG This study 
 86-24 ∆sepL sepL::pTOPO-2HA This study 
 86-24 ∆sepL∆qseG sepL::pTOPO-2HA This study 
Yeast L40 Yeast reporter strain MATa, trp1, leu2, his3, LYS2::lexA-
HIS3, URA3::lexA-LacZ 
(52) 
  B2HPC L40 transformed with  pLX-YopJ + pVP-MEKK “Yeast-2-
Hybrid Positive Control" 
(62) 
B2HNC L40 transformed with pLX-Laminin + pVP16 “Yeast-2-
Hybrid Negative Control” 
(62) 
SL1344 StreptomycinR Salmonella enteria serovar Typhimurium (63) 
 SL1344 ∆qseG This study 
 SL1344 ∆invA∆spiB (59) 
 SL1344 ∆qseG qseG::pBAD/Myc-His This study 
SW762 
(∆fliC∆fljB) 
SL1344 ∆fliC fljB5001::MudJ (64) 
 SL1344 ∆qseG∆fljB This study 
 2 
 3 
Plasmid  Reference 
pKD3 λ red template plasmid (50) 
pKD46 λ red helper plasmid (50) 
pCP20 λ red helper plasmid (50) 
SepL-HA sepL::pTOPO-2HA (14) 
QseGpBAD Stm qseG under araBAD promoter in pBAD/Myc-His A This study 
pLex-ADB Yeast two hybrid  
QseG-Lex 
 
Yeast Two hybrid This study 
SepL-Lex Yeast two hybrid This study 
pVP16 Yeast two hybrid This study 
EspD-VP16 
 
Yeast two hybrid This study 
SepD-VP16 Yeast two hybrid This study 
EspA-VP16 Yeast two hybrid This study 
EscC-VP16 Yeast two hybrid This study 
SepL-VP16 Yeast two hybrid This study 
Tir-VP16 Yeast two hybrid This study 
 29 
Table 3. Primers  1 
Primer Sequence 5’-3’ use 
SL_qseG_Redf ggaagtttgttttcgcatctcgctgccattgcctgcatctgacaaacacta
atGTGTAGGCTGGAGCTGCTTC 
 
Stm qseG KO 
SL_qseG_Redr 
 
gtaatccgggatcgtcatcgaccagcagcaggtgcgccggtttacggct
taCATATGAATATCCTCCTTAG  
 
Stm qseG KO 
SL_qseG_REDcheckF ggaagtttgttttcgcatctcgctgcc Confirming Stm qseG KO 
SL_qseG_REDcheckR gtaatccgggatcgtcatcgaccagc Confirming Stm qseG KO 
STMqseG_pBADmychisf
wd xhoI 
 
CCGCTCGAGGAATTTAAGCCTGGTGCGTATGTCAC 
 
Stm qseG complementation 
STMqseG_pBADmychisr
ev hindIII 
 
GCCAAGCTTTGGCGTTACCTCATCTTGTGACG Stm qseG complementation 
Stm_rpoA_RTfwd 
 
CGCGGTCGTGGTTATGTG 
 
Stm qPCR 
Stm_rpoA_RTrev 
 
GCGCTCATCTTCTTCCGAAT 
 
Stm qPCR 
Stm_fljB_RTfwd 
 
GGTACTACACTGGATGTATCG 
 
Stm qPCR 
Stm_fljB_Rtrev 
 
CGTAGCCGCTTTAATAGC 
 
Stm qPCR 
Stm_fliC_RTfwd 
 
GGTGGTAAAACTTACGCTG 
 
Stm qPCR 
Stm_fliC_RTrev 
 
GATCAGGCTGTGCTTTAAAG 
 
Stm qPCR 
Stm_Hinversion_Univ 
 
GCGCATTACGCTGTAAATCG 
 
fljB promoter orientation 
Stm_Hinversion_ON 
 
gcggggcaatttaatggtgtccgg 
 
fljB promoter orientation 
Stm_Hinversion_OFF 
 
cgcgctgttgatacgcagacc 
 
fljB promoter orientation 
fljB_RED_fwd 
 
GCACAAGTAATCAACACTAACAGTCTGTCGCTGCTGAC
CCAGAATAACCGTGTAGGCTGGAGCTGCTTC  
 
fljB KO 
fljB_RED_rev 
 
CAGAGACAGCACGTTCTGCGGGACCTGGTTAGCCTGC
GCCAGAACGGCATATGAATATCCTCCTTAG  
 
fljB KO 
fljB_up GCACAAGTAATCAACACTAAC 
 
Screen fljB KO  
fljA_down 
 
GTAGTCCGAAGACGTGATCC 
 
Screen fljB KO 
hIL8_RTfwd 
 
ATGACTTCCAAGCTGGCCG 
 
Human IL8 qPCR 
hIL8_RTrev 
 
CTCAGCCCTCTTCAAAAACTT 
 
Human IL8 qPCR 
hGAPDH_RTfwd AATCCCATCACCATCTTCCA Human GAPDH qPCR 
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hGAPDH_RTrev 
 
TGGACTCCACGACGTACTCA 
 
Human GAPDH qPCR 
mNOS2_RT_fwd 
 
ccagccttgcatcctcattgg 
 
Mouse NOS2 qPCR 
mNOS2_RT_rev 
 
ccaaacaccaagctcatgcgg 
 
Mouse NOS2 qPCR 
mGAPDH_RT_fwd 
 
aggtcggtgtgaacggatttg 
 
Mouse GAPDH qPCR 
mGAPDH_RT_rev 
 
tgtagaccatgtagttgaggtca 
 
Mouse GAPDH qPCR 
TirVP16F 
 
CAA GGA TCC ACA GCATG CCT ATT GGT AAT CTT G 
 
Yeast two hybrid 
TirVP16R 
 
CAA TGC GGC CGC TTA GAC GAA ACG ATG GGA TC  
 
Yeast two hybrid 
SepLVP16F 
 
CCA GGA TCC ACA GCA TGG CTA ATG GTA TTG  
 
Yeast two hybrid 
SepLVP16R 
 
CAA TGC GGC CGC TCA AAT AAT TTC CTC CTT ATA G 
 
Yeast two hybrid 
SepDVP16F 
 
CACGG ATC CCC GGC ATG AAC AAT AAT AAT GGC  
 
Yeast two hybrid 
SepDVP16R 
 
CAAT GCG GCC G CT TAC ACA ATT CGT CCT ATA TC 
 
Yeast two hybrid 
EspAVP16F 
 
CAA GGA TCC ACA GCA TGG ATA CAT CAA ATG CAA 
CAT CC 
 
Yeast two hybrid 
EspAVP16R 
 
CAA TGC GGC CGC TTA TTT ACC AAG GGA TAT TGC 
TG 
 
Yeast two hybrid 
EscCVP16F 
 
CAAGG ATC CCC GGC CGA TAT AGG ACG AAT TGT 
GTA ATG 
 
Yeast two hybrid 
EscCVP16R 
 
CATT GCG GCC GCT TAT TCG CTA GAT GCA GAT TTT 
ATC  
 
Yeast two hybrid 
QseGVP16F 
 
CAA GGA TCC ACA GC AT GCG ACA CAT TTT TCA ACG  
 
Yeast two hybrid 
QseGVP16R 
 
CAA TGC GGC CGC TTA TGG CTC ATC AGG AGT GAC 
C 
 
Yeast two hybrid 
SepLLexF 
 
CACGA ATT CCC C  ATGGCTAATGGTATTG 
 
Yeast two hybrid 
SepLLexR 
 
CAA CTG CAG TCA AAT AAT TTC CTC CTT ATA G 
 
Yeast two hybrid 
QseGLexF 
 
CACGA ATT CCC CAT GCG ACA CAT TTT TCA ACG  
 
Yeast two hybrid 
QseGLesR 
 
CAA CTG CAG TTA TGG CTC ATC AGG AGT GAC C 
 
Yeast two hybrid 
SepLREDF 
 
TGGCTAATGGTATTGAATTTAATCAAAACCCCGCATCT
GTTTTTAATTCTAATTCATTAG 
GTGTAGGCTGGAGCTGCTTC 
 
EHEC knockout 
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SepLREDR 
 
TAATTTCCTCCTTATAGTCGATAACTTTACCAATCATTAA
TAATGCATTCTCTCTCTGCT 
CATATGAATATCCTCCTTAG 
 
EHEC knockout 
 1 
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 5 
 6 
 7 
 8 
 9 
 10 
 11 
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 17 
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 19 
 20 
 21 
 22 
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Figure legends 1 
 2 
FIG 1 QseG interacts with SepL. (A) Proteinase K protection assays of OmpA and QseG. WT 3 
EHEC cells were treated with proteinase K and then proteins were analyzed by western blot. 4 
Known outer-membrane protein OmpA is included as a control (B) Yeast two hybrid assays to 5 
probe possible protein-protein interaction between QseG and QseG, EscC, EspA, SepD, SepL 6 
and Tir.  Briefly, the yeast report strain L40 was transformed with all combinations of the 7 
proteins in both the bait (pLEX-ADE) and the library (pVP16) vector. Dual transformants were 8 
selected on yeast minimal media lacking leucine, and tryptophan and then assayed for protein-9 
protein interactions using the integrated LacZ and HIS3 reporters.  Association of the two protein 10 
fusions was determined by growth on yeast minimal media lacking histadine.  (C) Pull down 11 
assays with SepL-HA and QseG.  A plasmid expressing an HA-tagged sepL allele was 12 
transformed into ∆sepL and ∆sepL∆qseG EHEC strains. SepL was captured using HA antisera 13 
and the precipitate was probed for QseG by western blot using QseG antisera. 14 
 15 
FIG 2 AE lesion timing and dynamics. Time lapse microscopy of Lifeact::GFP expressing HeLa 16 
cells being infected with mCherry expressing WT and ∆qseG EHEC. The minutes elapsed after 17 
imaging was begun are listed above each panel. EHEC pedestal formation can be observed as 18 
yellow areas—where actin polymerization (green puncta) co-localizes with attached EHEC 19 
bacteria (red). 20 
 21 
FIG 3 QseG is necessary for EHEC and C. rodentium virulence. (A) EHEC infection in infant 22 
rabbits. 3-day old rabbits were inoculated intragastrically with ~5x108 CFU or WT or ∆qseG 23 
 33 
EHEC. At 5 days post infection colonic contents was plated on LB containing streptomycin to 1 
determine EHEC CFUs **p<0.01. Citrobacter rodentium murine infections. 3.5 week old 2 
C3H/HeJ mice were gavaged with 109 CFU of WT or ∆qseG C. rodentium or PBS. (B) survival 3 
was monitored daily (n=10). Statistical significance was determined via Kaplan Meyer test (C) 4 
Colon weight. Mice were infected as described in B (n=5). At day 6 post infection mice were 5 
sacrificed, and their colons collected, washed and weighed.  (D) Colons collected as described in 6 
C were examined for gross pathology differences. 7 
 8 
FIG 4 QseG controls flagellin phase variation in Salmonella enterica Typhimurium (Stm). (A) 9 
Nucleotide and protein sequence similarities of qseE, qseF and qseG between EHEC and Stm are 10 
displayed (B) Stm strains were grown statically in LB broth to late log phase. A standard amount 11 
of BSA was spiked into cultures just prior to collection to serve as a concentrating/loading 12 
control. Cells were pelleted and proteins in filtered, concentrated supernatants were separated via 13 
SDS-PAGE and stained using Coomaisie blue. Presumed identifications of selected proteins 14 
based on molecular weight are indicated and the band of interest that is overexpressed in the 15 
qseG mutant supernatant is indicated with an asterisk. Relative quantification of FljB and FliC 16 
levels from the pictured supernatants was performed via LC-MS/MS and is listed below.  (C) 17 
WT, ∆qseG and the complemented strain were grown to OD 1.0 in LB broth + 0.2% arabinose to 18 
induce the complementation plasmid. RNA extracted from these cells was probed via qPCR for 19 
expression levels of fliC and fljB. Levels of genes of interest were normalized to rpoA levels and 20 
expressed as a fold change over WT levels. The average and standard deviation of three 21 
replicates is shown. (D) Using a qPCR-based assay, the orientation of the fljB promoter was 22 
assessed in Stm grown as described in 3B. The data is displayed as the molar on:off ratio of the 23 
 34 
fljB promoter. The average and standard deviation of three replicates is shown and a student’s t-1 
test was used to determine statistical significance.  2 
 3 
FIG 5 QseG does not contribute to motility, cell invasion or intracellular replication in Stm. (A) 4 
Indicated Stm strains were grown to OD 1.0 in LB broth + 0.2% arabinose (to induce 5 
complementation plasmid) then stabbed into 0.3% agar LB plates. At 6,8 and 24 hours the 6 
diameter of the motility halos were measured. Averages and standard deviations from three 7 
replicates are reported and representative plates at 24 hours are pictured. (B) HeLa cells were 8 
infected with the indicated Stm strains to assess cell invasion efficiency. The ∆invA∆spiB mutant 9 
represents an invasion deficient strain. Averages and standard deviations from three replicates 10 
are shown. (C) J774 (mouse) or THP1 (human) macrophages were infected with the indicated 11 
Stm strains to assess intracellular replication ability. The ∆invA∆spiB mutant represents a 12 
intracellular replication deficient strain. The averages and standard deviation of three replicates 13 
are shown. 14 
 15 
FIG 6 QseG impacts Stm murine infection.  Balb/c mice were mice were infected 16 
intraperitoneally with 1x104 CFU of the indicated Stm strain or sterile PBS. Survival (A) and 17 
weight (B) were monitored over time. Data from two independent experiments, each using 10 18 
mice per group, are displayed in A and B. Significant differences between survival curves were 19 
determined using the Mantel-Cox method. (C) On day 2 (top) or 3 (bottom), 5 mice were 20 
randomly selected, sacrificed and serial dilutions of organ homogenates plated for CFU counts.  21 
 22 
 35 
FIG 7 Altered inflammation during murine infection by the qseG Stm mutant.  (A) Concentrated 1 
supernatants from the indicated Stm strains were applied to T84 intestinal epithelial cells. 2 
Induction of IL-8 transcription was assessed via qPCR. IL-8 levels were normalized to GAPDH 3 
levels and values are reported as a fold change over uninfected cells. The averages and standard 4 
deviations from three replicates are displayed and statistical significance was determined using a 5 
student’s t-test.  (B) From the murine infection experiment described in Figure 6, total DNA was 6 
extracted from infected spleens and livers on Day 3 post-infection. The orientation of the fljB 7 
promoter was assayed via the qPCR-based method described in Fig. 3C (n=5). Significant 8 
differences were determined using a student’s t-test. (C) From the infection experiment described 9 
in Figure 6, total RNA was extracted from infected spleens and livers on Day 3 post-infection. 10 
Host NOS2 expression levels were assayed via qPCR, normalized to GAPDH levels and reported 11 
as a fold change over levels from PBS treated mice. (n=5) Significant differences were 12 
determined using a student’s t-test 13 
 14 
FIG 8 Model of the role of QseG in Stm. Flagellin expression is advantageous during the 15 
intestinal portion of the life cycle and the intestinal Stm population is mixed: with some 16 
expressing FliC and others FljB. Once the bacteria cross the epithelial barrier and go systemic, 17 
flagellin expression is no longer advantageous. Flagellin secretion at systemic sites, particularly 18 
FljB, can lead to an increased inflammatory response and an attenuated infection. QseG is 19 
involved in limiting the inflammatory response to flagellin, and modulates the fljB promoter such 20 
that the off orientation is favored. This leads to less FljB secretion, lowered NOS2 induction by 21 
the host and a more virulent phenotype in a mouse model of systemic infection. 22 
 23 
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SUPPLEMENTAL MATERIAL 
SUPPLEMENTAL FILE 1, live cell movie of WT EHEC on HeLa cells 
SUPPLEMENTAL FILE 2, live cell movie of ∆qseG EHEC on HeLa cells 
 
